The study analyzed patients from Rochester, Minn.-based Mayo Clinic from Feb. 27 to July 22. It involved 8,889 patients who received Johnson & Johnson’s vaccine and 88,898 unvaccinated patients.
Sixty of the vaccinated patients tested positive for COVID-19, while 2,236 of the unvaccinated patients tested positive. Infection data was determined by PCR tests.
The researchers concluded that the vaccine led to a 3.73-fold reduction in infections.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
